First Singapore case of cannabis-derived medication allowed

Marijuana plants being grown at a facility in Smiths Falls, Ontario, Canada, on Oct 29, 2019.
Marijuana plants being grown at a facility in Smiths Falls, Ontario, Canada, on Oct 29, 2019.PHOTO: REUTERS

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication.

Suffering from refractory epilepsy, the girl failed to respond to therapies and had exhausted all currently registered medications for treatment, the Ministry of Home Affairs (MHA) told The Sunday Times.

Please or to continue reading the full article.

Get unlimited access to all stories at $0.99/month

  • Latest headlines and exclusive stories
  • In-depth analyses and award-winning multimedia content
  • Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

A version of this article appeared in the print edition of The Sunday Times on December 01, 2019, with the headline 'First S'pore case of cannabis-derived medication allowed'. Print Edition | Subscribe